Oncternal Therapeutics Statistics
Total Valuation
ONCT has a market cap or net worth of $1.56 million. The enterprise value is -$12.83 million.
| Market Cap | 1.56M |
| Enterprise Value | -12.83M |
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ONCT has 2.96 million shares outstanding. The number of shares has increased by 1.60% in one year.
| Current Share Class | 2.96M |
| Shares Outstanding | 2.96M |
| Shares Change (YoY) | +1.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 13.33% |
| Float | 2.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 2.07 |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.39 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -149.86% and return on invested capital (ROIC) is -93.35%.
| Return on Equity (ROE) | -149.86% |
| Return on Assets (ROA) | -74.11% |
| Return on Capital (ROIC) | -93.35% |
| Revenue Per Employee | $72,033 |
| Profits Per Employee | -$1.15M |
| Employee Count | 30 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.30% in the last 52 weeks. The beta is 1.20, so ONCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -92.30% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 5.83 |
| Relative Strength Index (RSI) | 25.20 |
| Average Volume (20 Days) | 198,897 |
Short Selling Information
The latest short interest is 14,209, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 14,209 |
| Short Previous Month | 45,352 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.53% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, ONCT had revenue of $2.16 million and -$34.58 million in losses. Loss per share was -$11.69.
| Revenue | 2.16M |
| Gross Profit | -22.93M |
| Operating Income | -34.86M |
| Pretax Income | -35.97M |
| Net Income | -34.58M |
| EBITDA | n/a |
| EBIT | -34.86M |
| Loss Per Share | -$11.69 |
Balance Sheet
The company has $14.58 million in cash and $191,000 in debt, giving a net cash position of $14.39 million or $4.86 per share.
| Cash & Cash Equivalents | 14.58M |
| Total Debt | 191,000 |
| Net Cash | 14.39M |
| Net Cash Per Share | $4.86 |
| Equity (Book Value) | 9.15M |
| Book Value Per Share | 3.09 |
| Working Capital | 8.99M |
Cash Flow
| Operating Cash Flow | -26.63M |
| Capital Expenditures | n/a |
| Free Cash Flow | -26.63M |
| FCF Per Share | -$9.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,613.10% |
| Pretax Margin | -1,599.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,364.68% |
Dividends & Yields
ONCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.60% |
| Shareholder Yield | -1.60% |
| Earnings Yield | -2,218.41% |
| FCF Yield | -1,708.77% |
Analyst Forecast
The average price target for ONCT is $10.00, which is 1,798.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 1,798.98% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 8, 2024. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Jan 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
ONCT has an Altman Z-Score of -24.56 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.56 |
| Piotroski F-Score | 3 |